… response) may have an increased clinical role in the near future. Furthermore, some serum
biomarkers are … and foreseen future of HCC biomarkers implicated in surveillance, diagnosis, …

Background Hepatocellular carcinoma (HCC) is a common illness that affects patients
worldwide. The disease remains poorly understood though several recent advances have …

… In conclusion, this hypothesis-generating study for biomarkers predicting response to
regorafenib treatment in HCC has led to the identification of protein and miRNA biomarker …

The pathogenesis of hepatocellular carcinoma (HCC) strongly relates to inflammation, with
chronic up‐regulation of pro‐inflammatory mediators standing as a potential unifying …

… biomarker of this tumor. To improve performance, combinations of biomarkers (panels), or
combinations of biomarkers … We describe recently discovered biomarkers of HCC and discuss …

… response and survival benefit from immunotherapy have become an area of high unmet
need in HCC. Predictive biomarkers … of predictive biomarkers of response to immune-based …

… imaging biomarkers and the criteria of response evaluation … response. In this review, we
discuss various established, evolving and emerging imaging biomarkers, the criteria of response …

… potential of HCC and treatment response to specific therapies. … biomarkers and novel
biomarkers have been tested to improve sensitivity and specificity. In practical terms, biomarkers …

… In this Review, we provide a summary of the current status of biomarker development in
HCC. We also provide some insights into potential novel biomarkers and the most promising …

… understanding the biomarkers that predict clinical response to … the key predictive and prognostic
biomarkers investigated in … use of TILs as a biomarker of response to neoadjuvant ICIs in …